Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults
Clinical trial NCT04232280 · COMPLETED
Trial details
- NCT number
- NCT04232280
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-09
- Primary completion
- 2023-01-04
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.